Our look at interesting news, research and healthcare policy from this year’s conference
A new study finds that the Ottawa Model for Smoking Cessation saves lives and eases the demand for healthcare resources
The genetic basis of heart disease is largely due to a combination of many common genetic variants having a small impact, rather than a few rare variants with large effects
The PCSK9 protein, much promoted as the target for a new class of cholesterol-lowering drugs, is found at higher levels in patients undergoing a heart attack.
Dr. Thierry Mesana discusses the future of cardiovascular care, the importance of research and what makes the Heart Institute special.
Whether to continue the anticoagulant warfarin for device implantations has been an open question for some time. Now, new Heart Institute research looks to have closed the debate.
Committed to expanding the options for treating patients with structural heart disease.